Episode Details
Back to EpisodesThe Health Marketing Daily | Mikrobiom-Modulation als Therapieansatz beim Reizdarmsyndrom | Ferrero to buy better-for-you breakfast brand | FDA lays out plan to close
Published 1 month, 2 weeks ago
Description
The Health Marketing Daily — August 17, 2026
In this episode:
• Germany's updated S3 clinical guideline on IBS now formally recognises microbiome modulation as a therapeutic approach — a significant validation moment for probiotic and gut health brands operating in Europe's largest market.
• Ferrero's acquisition of Purely Elizabeth signals that major confectionery incumbents are now aggressively buying into the better-for-you breakfast and wellness food space — not just dabbling at the edges.
• The FDA's move to close the GRAS self-determination loophole — requiring mandatory notification for ingredients previously self-affirmed as safe — is the most significant US food ingredient regulatory shift in decades, with downstream implications for functional food and supplement formulation globally.
• Khloé Kardashian's Khloud brand is taking collagen — long a premium supplement category — into mass-market snack format via a Walmart-exclusive launch, signalling a major channel and format shift for functional ingredients.
Hosted by Marco & Klara. New episode every weekday.
Tags: health marketing, nutraceuticals, supplements, functional nutrition, wellness, clinical evidence, regulatory, consumer health